Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients

Journal of Neuroimmunology

Volumn 82, Issue 1, 1998, Pages 5-12

  Ciusani, Emilio ^a   Frigerio, Simona ^a   Gelati, Maurizio ^a   Corsini, Elena ^a   Dufour, Anna ^a   Nespolo, Angelo ^a   La Mantia, Loredana ^a   Milanese, Clara ^a   Massa, Giorgio ^a   Salmaggi, Andrea ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Apoptosis; Cerebro spinal fluid; Fas; Multiple sclerosis

Indexed keywords

ALBUMIN; FAS ANTIGEN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANTIGEN DETECTION; APOPTOSIS; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; FEMALE; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

ADULT; ALBUMINS; ANTIGENS, CD95; APOPTOSIS; BLOOD-BRAIN BARRIER; CEREBROSPINAL FLUID; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; SERUM ALBUMIN; SOLUBILITY;

EID: 0032006726     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00177-X     Document Type: Article

References (30)

1. Abbas A.K. Die and let live: Eliminating dangerous lymphocytes. Cell. 84:1996;655-657.
2. Bansil S., Holtz C.R., Cook S.D., Rohowsky-Kochan C. Serum sApo-1/Fas levels in multiple sclerosis. Acta Neurol. Scand. 95:1997;208-210.
3. Bonetti B., Raine C.S. Multiple sclerosis: Oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann. Neurol. 42:1997;74-84.
4. Cascino I., Fiucci G., Papoff G., Ruberti G. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J. Immunol. 154:1995;2706-2713.
5. Cheng J., Zhou T., Liu C., Shapiro J.P., Brauer M.J., Kiefer M.C., Barr P.J., Mountz J.D. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 263:1994;1759-1762.
6. Cohen J.J. Apoptosis. Immunol. Today. 14:1993;126-130.
7. Critchfield J.M., Racke M.K., Zúñiga-Pflücker J.C., Cannella B., Raine C.S., Govermann J., Lenardo M.J. T-cell deletion in high antigen-dose therapy of autoimmune encephalomyelitis. Science. 263:1994;1139-1143.
8. D'Souza S.D., Bonetti B., Balasingam V., Cashman N.R., Baker P.A., Troutt A.B., Raine C.S., Antel J.P. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J. Exp. Med. 184:1996;2361-2370.
9. Dhein J., Walczak H., Bäumler C., Debatin K.M., Krammer P.H. Autocrine T-cell suicide mediated by Apo-1/(Fas/CD95). Nature. 373:1995;438-441.
10. Dowling P., Bansil S., Menonna J., Husar W., Cook S. Programmed cell death in multiple sclerosis brain. Ann. Neurol. 38:1995;341.
11. Dowling P., Shang G., Raval S., Menonna J., Cook S., Housar W. Involvement or the CD95 (Apo-1/Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med. 184:1996;1513-1518.
12. Fukunaga R.W., Brannan C.I., Copeland N.G., Jenkins N.A., Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediate apoptosis. Nature. 356:1992;314-317.
13. Gold R., Schmied M., Tontsch U., Hartung H.P., Wekerle H., Toyka K.V., Lassmann H. Antigen presentation by astrocyte primes rat T-lymphocytes for apoptotic cell death. A model for T-cell apoptosis in vivo. Brain. 119:1996;651-659.
14. Griffith T.G., Brunnet T., Fletcher S.M., Douglas R.G., Ferguson T.A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 270:1995;1189-1192.
15. Ichikawa H., Ota K., Iwata M. Increased Fas antigen on T cells in multiple sclerosis. J. Neuroimmunol. 71:1996;125-129.
16. Inoue A., Koh C.S., Sakai T., Yamazaki M., Yanagisawa N., Usuku K., Osame M. Detection of the soluble form of the Fas molecule in patients with multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy. J. Neuroimmunol. 75:1997;141-146.
17. Kägi D., Vignaux F., Ledermann B., Bürki K., Depraetere V., Nagata S., Hengartner H., Golstein P. Fas and perforin pathways as major mechanisms of T-cell mediated cytotoxicity. Science. 265:1994;230-528.
18. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology. 33:1983;1444-1452.
19. Lee S., Chistakos S., Small M.B. Apoptosis and signal transduction: Clues to a molecular mechanism. Curr. Opin. Cell Biol. 5:1993;286-291.
20. Nieto L.A., Lopez Rivas A. IL-2 protects T-lymphocytes from glucocorticoid induced DNA fragmentation and cell death. J. Immunol. 143:1989;4166-4172.
21. Papoff G., Cascino I., Eramo A., Starace G., Lynch D.H., Ruberti G. An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro. J. Immunol. 156:1996;4622-4630.
22. Pelfrey C.M., Tranquill L.R., Boehme S.A., McFarland H.F., Lenardo M.J. Two mechanisms of antigen specific apoptosis of myelin basic protein (MBP)-specific T-lymphocytes derived from multiple sclerosis patients and normal individuals. J. Immunol. 154:1995;6191-6202.
23. Poser, C.M., Paty, D.W., McDonald, W.I., Scheinberg, L., Ebers, G.C., 1984. The Diagnosis of Multiple Sclerosis. Thieme-Straton, New York.
24. Schmied M., Breitschopf H., Gold R., Zischler H., Rothe G., Wekerle H., Lassmann H. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am. J. Pathol. 143:1993;446-452.
25. Singer G.G., Carrera A.C., Marshak-Rothstein A., Martinez-A C., Abbas A.K. Apoptosis, Fas and systemic autoimmunity: The MRL-lpr/lpr model. Curr. Opin. Immunol. 6:1994;913-920.
26. Spinozzi F., Agea E., Bistoni O., Travetti A., Migliorati G., Moraka R., Nicoletti I., Riccardi C., Paoletti F.P., Vaccaro R., Bertotto A. T-lymphocytes bearing the γδ T-cell receptor are susceptible to steroid induced programmed cell death. Scand. J. Immunol. 41:1995;504-508.
27. Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1993;1169-1180.
28. Takahaschi H., Kobayashi H., Hashimoto Y., Matsu S., Iizuka H. Interferon-gamma-dependent stimulation of Fas antigen in SV40-transformed human keratinocytes: Modulation of the apoptotic process by protein kinase C. J. Invest. Dermatol. 105:1995;810-815.
29. Tourtellotte W.W., Ma B.I. Multiple sclerosis: The blood-brain barrier and the measurement of de novo central nervous system IgG synthesis. Neurology. 28(9 (part II)):1978;76-83.
30. Zipp F., Weller M., Dichgans J., Martin R. Elevated CD-95 (Apo-1) serum level in relapsing-remitting multiple sclerosis. Neurology. 48(3):1997;A426.